Diagnostic companies shift
attention to multiplex tests for COVID-19, flu
|
|
Several
companies have launched, or plan to launch, multiplex molecular tests to help
providers determine which virus a patient may have and then treat them
appropriately.
|
Wednesday, September 9, 2020
Diagnostic companies shift attention to multiplex tests for COVID-19, flu
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment